Quién puede participar

AE, AZ, BA, BE, BH, BY, CL, CN, CZ, DE, EE, FR, GB, GE, KG, KW, KZ, LT, LV, MD, MN, MY, PH, PL, QA, RU, SA, SI, SK, TM, UA, UZ, VN

Premio financiero

19 000 €

Jurado internacional

Natalia Viacheslavovna Kharchenko (UKR), Elena Borisovna Zueva (UZB), Marek Hartleb (POL), Elena Nikolaevna Shirokova (RUS), Natalia Nikolaevna Silivontchik (BLR), Petr Hůlek (CZE), Gediminas Kiudelis (LTU)

Trabajos ganadores

1.er lugar: Jerzy Ostrowski

A heterozygous mutation in GOT1 is associated with familial macro-aspartate aminotransferase
Kulecka M., Wierzbicka A., Paziewska A., Mikula M., Habior A., Janczyk W., Dabrowska M., Karczmarski J., Lazniewski M., Ginalski K., Czlonkowska A., Socha P., Ostrowski J.

2.o lugar: Jan Kral

Expression profile of miR-17/92 cluster is predictive of treatment response in rectal cancer
Kral J., Korenkova V., Novosadova V., Langerova L., Schneiderova M., Liska V., Levy M., Veskrnova V., Spicak J., Opattova A., Jiraskova K., Vymetalkova V., Vodicka P., Slyskova J.

3.er lugar: Juozas Kupcinskas

PNPLA3 and RNF7 Gene Variants are Associated with the Risk of Developing Liver Fibrosis and Cirrhosis in an Eastern European Population
Kupcinskas J., Valantiene I., Varkalaitė G., Steponaitiene R., Skieceviciene J., Sumskiene J., Petrenkiene V., Kondrackiene J., Kiudelis G., Lammert F., Kupcinskas L.

Los siguientes artículos pasaron al nivel internacional de la evaluación

Decolonization of Intestinal Carriage of MDR/XDR Gram-Negative Bacteria with Oral Colistin in Patients with Hematological Malignancies: Results of a Randomized Controlled Trial
Stoma I., Karpov I., Iskrov I., Krivenko S., Uss A., Vlasenkova S., Lendina I., Cherniak V., Suvorov D.

Acute-on-chronic liver failure
Silivontchik N.N., Haurylenka D.I.

Some features of itestinal metaplasia in children
Marakhouski K., Kletski S., Devialtovskaya M.

Expression profile of miR-17/92 cluster is predictive of treatment response in rectal cancer
Kral J., Korenkova V., Novosadova V., Langerova L., Schneiderova M., Liska V., Levy M., Veskrnova V., Spicak J., Opattova A., Jiraskova K., Vymetalkova V., Vodicka P., Slyskova J.

Mitotic and apoptotic activity in colorectal neoplasia
Kohoutova D., Pejchal J., Bures J.

Per-oral endoscopic myotomy (POEM): mid-term efficacy and safety
Martinek J., Svecova H., Vackova Z., Dolezel R., Ngo O., Krajciova J., Kieslichova E., Janousek R., Pazdro A., Harustiak T., Zdrhova L., Loudova P., Stirand P., Spicak J.

Uric acid metabolism disorder in case of metabolic syndrome
Aringazina R., Bazargaliyev Y., Bekkuzhin A., Kurmanalina G., Suleimenov K.

PNPLA3 and RNF7 Gene Variants are Associated with the Risk of Developing Liver Fibrosis and Cirrhosis in an Eastern European Population
Kupcinskas J., Valantiene I., Varkalaitė G., Steponaitiene R., Skieceviciene J., Sumskiene J., Petrenkiene V., Kondrackiene J., Kiudelis G., Lammert F., Kupcinskas L.

Non-alcoholic fatty liver and advanced fibrosis in the elderly: Results from a community-based Polish survey
Hartleb M., Barański K., Zejda J., Chudek J., Więcek A.

Elevated systemic interleukin-7 in patients with colorectal cancer and individuals at high risk of cancer: association with lymph node involvement and tumor location in the right colon
Krzystek-Korpacka M., Zawadzki M., Neubauer K., Bednarz-Misa I., Górska S., Wiśniewski J., Witkiewicz W., Gamian A.

A heterozygous mutation in GOT1 is associated with familial macro-aspartate aminotransferase
Kulecka M., Wierzbicka A., Paziewska A., Mikula M., Habior A., Janczyk W., Dabrowska M., Karczmarski J., Lazniewski M., Ginalski K., Czlonkowska A., Socha P., Ostrowski J.

Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study
Nadinskaia M.Yu., Kodzoeva Kh.B., Ulyanova K.A., Volkova A.S., Rogacheva S.I., Dekhanov A.S., Strelkova D.A., Ivashkin V.T. 

Characteristics of primary sclerosing cholangitis concomitant with inflammatory bowel disease
Pazenko E.V., Raikhelson K.L., Kondrashinа E.A., Gabrusskaya T.B., Gerasimova O.A.

Clinical and laboratory markers for predicting liver fibrosis in individuals with non-alcoholic fatty liver disease
Krolevets T.S., Livzan M.A.

Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
Drazilova S., Janicko M., Skladany L., Kristian P., Oltman M., Szantova M., Krkoska D., Mazuchova E., Piesecka L., Vahalova V., Rac M., Schreter I., Virag L., Koller T., Liptakova A., Ondrasova M., Jarcuska P.

Effectiveness of nonalcoholic steatohepatitis correction on the baсkground of obesity with concomitant chronic kidney disease
Khukhlina O., Antoniv A., Kanovska L., Mandryk O., Smandych V.

Endocrine masks of abdominal syndrome: the visceropathic form of primary hyperparathyroidism (case study)
Havrylyuk N.S.

Prognostic marker of liver fibrosis in patients with chronic viral hepatitis B and D
Abdukadirova M., Khikmatullaeva A., Musabaev E., Ibadullaeva N.

Prevalence of helicobacter-associated disease of gastrointestinal tract in Uzbekistan
Karimov M.M., Ismailova Zh.A., Sobirova G.N., Saatov Z.Z.

GG Genotype of Pnpla3 Rs38409 Polymorphism Associated with Nash in Patients of Uzbek Nationality
Sobirova G.N., Khamroeva D.M., Karimov M.M., Alyavi A.L., Adilov B.Sh.